FIGURE 2.
Mechanisms of action of agents in Phase 3 (as classified using the CADRO approach). CADRO, Common Alzheimer's Disease Research Ontology; DMT, disease‐modifying therapy. (Figure © J Cummings; M de la Flor, PhD, Illustrator).
Mechanisms of action of agents in Phase 3 (as classified using the CADRO approach). CADRO, Common Alzheimer's Disease Research Ontology; DMT, disease‐modifying therapy. (Figure © J Cummings; M de la Flor, PhD, Illustrator).